Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cannabit is an Israeli medical cannabis company that focuses on the research, cultivation, and distribution of pharmaceutical-grade cannabis products. The company gained significant prominence after acquiring the Israeli operations of Tikun Olam, a pioneer in the global medical cannabis industry. Cannabit operates advanced cultivation facilities and a specialized manufacturing plant that adheres to EU-GMP standards. Their product portfolio includes various oils, flowers, and specialized delivery systems designed for clinical applications in treating conditions such as chronic pain, epilepsy, and gastrointestinal disorders. The company is actively involved in clinical trials to validate the efficacy of specific cannabinoid ratios for diverse medical indications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cannabit.